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Abstract - During the last decade, the important role of gut microflora as a special organ of the gastrointestinal system in 
the metabolism of drugs is well known. The aim of this study was to evaluate the role of the gut microecological popula-
tion with enzymatic systems, especially beta-lyase, in the metabolism of paracetamol in mice. Two groups of 20 white 
male laboratory mice BALB/c, body weight 32+/-1.5 kg, were treated orally with neomycin sulphate (500 mg/kg in saline 
solution) and saline solution (10 ml/kg) twice daily for three days. After the treatment, the animals were given paracetamol 
dissolved in saline solution (200 mg/kg) intraperitoneally. The total amount of excreted paracetamol in 8 hours’ collected 
urine was unchanged. A difference between treated and control mice was observed regarding a highly significant reduc-
tion in the excretion of 3-methylthiometabolites. A decrease in the excretion of thiomethyl metabolites was found in the 
control group compared to the experimental mice. Gut microflora had a great influence on the formation of metabolic 
precursors, thiomethyl-conjugates, and their oxidabile products. It is obvious that the ecosystem of gut microflora has an 
important role in the metabolism of paracetamol resulting in a significant reduction in the excretion of 3-methylthiopar-
acetamol by urine, the glucuronide and sulphate.
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INTRODUCTION
Many recent studies are dedicated to the metabolic 
role of gut micro flora. Conditions in the intestinal 
lumen allow for the presence of many thousands of 
bacterial strains, both aerobic and anaerobic (Sche-
line, 1973). Anaerobic bacteria are well known as 
bacteria that can live under extreme conditions re-
garding  different  temperatures,  salinity,  pH,  the 
presence of toxic substrates or available free energy 
(Larsen, 1985). Enzymes such as beta-lyase that are 
the result of gut flora activity have the possibility to 
transform conjugates of cysteine from xenobiotics in 
toxic metabolites. These toxic products are thiols or 
their metabolic products (Smith et al., 1978).
Gut  microflora  can  destroy  conjugates  of  glu-
tathione  in  appropriate  S-substituents  of  cysteine 
(Rowland, 1988). Data about the generation of thiols 
from conjugates of cysteine have been known for half 
a century, but recently the importance of metabolic 
pathways for forming different thiomethyl conjugates 
from many xenobiotics has been determined (Illet et 
al., 1990). In clinical practice, one of the most used 
drugs is paracetamol, whose metabolism depends on 
cytochrome-450, and which is inactivated by con-
jugation with glutathione (Mikov et al., 1988). This 
type of conjugate is excreted by urine as cysteine, 76 GORDANA BOJIĆ ET AL.
mercapturate and as methylthio-derivates. Gut mi-
croflora influence the paracetamol traveling through 
the gut system.
The aim of this research was to establish the place 
and the role of gut microflora in the formation of 
methylthio metabolites of paracetamol.
MATERIALS AND METHODS
In this study, two groups of 20 each male white labo-
ratory mice BALB/c, body weight 32+/-1.5gr, were 
treated with neomycin sulphate (500 mg/kg in saline 
solution) and saline solution (10 ml/kg) per os, twice 
daily for three days. The following day all the ani-
mals were given paracetamol (200 mg/kg) dissolved 
in saline solution intraperitoneally. After inoculation 
of paracetamol, each mouse was kept separately in 
a metabolic cage, which is suitable for collection of 
urine and feces. Samples of 8 hours’ urine were col-
lected in dark tubes and kept at 0°C. After 8 h incuba-
tion, each cage was washed with 5 ml of water (Dras-
ar, 1967). This liquid was added to the urine and kept 
at 20°C until the beginning of analysis (Aranki et al., 
1965). The animals had free access to food and water 
throughout the experiment. Separated metabolites of 
paracetamol were determined by HPLC. The results 
are presented as the mean+/-SD. Student’s t-test was 
used to determine the significant differences between 
the groups.
RESULTS
In the urine collected over 8 h, the concentrations 
of metabolites of paracetamol were measured (Gib-
son, 1985). It was found that the main metabolites 
excreted  by  urine  were  paracetamol  glucuronide, 
paracetamol  cysteinate  and  paracetamol  sulfate, 
unchanged  paracetamol,  methylthio  paracetamol 
and its glucuronide, sulfate and sulfoxide (Table 1). 
After treatment with neomycin, the total quantity 
of excreted paracetamol in 8 hours’ urine was not 
changed. Comparison of neomycin-pretreated mice 
and the control group revealed a highly significant 
reduction in the excretion of different 3-methylthi-
ometabolites in the neomycin-treated group (Stevens 
et al., 1986).
DISCUSSION
Paracetamol could be metabolized through three dif-
ferent pathways: conjugation with glucuronic acid, 
conjugation with sulfates, and metabolic activation 
by microsomal monooxygenases. This is the pathway 
for formation of reactive intermediary products that 
could be destroyed by conjugation with glutathione. 
Table 1. The excretion of paracetamol metabolites in 8 hours’ urine represented as relative value (%) of total intraperitoneally adminis-
tered paracetamol (N=20, *p<0.001).
Metabolites Control group
(X+/-SD)
Neomycin treated
Group (X+/- SD) 
Paracetamol
-glucuronide 45.6+/-9.25 43.5+/-4.25
-sulphate 8.15+/-2.31 8.7+/-6.55
-cysteinate 17.56+/-4.32 14.51+/-3.22
-unchangeable 4.56+/-1.11 4.36+/-1.24
-mercapturate  0.31+/-0.45 0.102+/-0.086
-thiomethyl sulfate and methyl sulfoxide 2.11+/-1.11 0.21+/-015*
-thiomethy glucuronide  0.54+/-+/-0.24 0.023+/-0.067*
-thiomethyl 0.1+/-0.12 0.034+/-0.054
total thiomethyl
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Such a conjugate with glutathione is mostly trans-
formed  before  elimination.  It  is  obvious  that  gut 
microflora contribute to the described occurrences 
in the metabolism of paracetamol as is seen in the 
confirmed  differences  between  the  experimental 
and control groups of mice. It is clear in the forma-
tion of 3-(methylthio)paracetamol. S-glutathionates 
are metabolized by hydrolysis in S-cysteinate which 
could be converted via three pathways: N-acetylation 
(when mercapturic acid is generated), transamina-
tion C-S cleavage, and separation of C-S cleavage.
It is well known that 3-thyoparacetamol is a very 
reactive compound that can contribute to drug toxic-
ity. It is very difficult to localize C-S lyases of conju-
gates of cysteine in tissue. Gut microflora has a cru-
cial contribution in this reaction (Freter, 1992).
In the group of neomycin-pretreated mice, the 
excretion of thiomethyl metabolites was decreased. 
While we cannot excluded the role of neomycin on 
the reabsorption of glutathione metabolites of para-
cetamol that are excreted by bile in intestine, a role 
for gut microflora in the metabolism of paracetamol 
has been shown (Mikov, 1991). Gut microflora gen-
erates the metabolic precursors of thiomethyl con-
jugates and their oxidized products (Schrezenmeiz, 
2012).
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